• Svenskasv
  • Englishen
  • EndoDrill®
    • Technology
    • Product portfolio
    • EndoDrill® GI
    • EndoDrill® EBUS
    • EndoDrill® URO
    • Clinical studies
    • Patents
  • About BiBB
    • BiBB in brief
    • Business strategy
    • Market
    • History
    • Board
    • Management
  • News & media
    • News and press releases
    • Media coverage
    • Congresses
    • Image gallery
    • Video library
  • Investor relations
  • Contact us
News & media

News and
press releases

  • Press Releases

May 19, 2025

BiBBInstruments AB: The subscription price for warrants of series TO 1 set at SEK 3.25 per share

BiBBInstruments AB (“BiBB” or the “Company”) issued a total of 2,755,282 warrants of series TO 1 (“the Warrants” or “TO1”) in...

Read more

  • Press Releases

May 15, 2025

BiBB Receives U.S. Patent Notice of Allowance for EndoDrill®

BiBBInstruments AB (“BiBB” or the “Company”), a cancer diagnostics company developing EndoDrill® – the world’s first market-cleared powered biopsy instrument for...

Read more

  • Press Releases

May 2, 2025

BiBB and TaeWoong Medical USA Sign Letter of Intent for U.S. Commercialization of EndoDrill® GI

BiBBInstruments AB (“BiBB” or “the Company”), developer of EndoDrill® – the world’s first market-cleared powered biopsy instrument for endoscopy – today...

Read more

  • Press Releases

April 7, 2025

BiBB Receives Notice of Allowance for Additional EndoDrill Patent in China

The cancer diagnostics company BiBB Instruments AB (“BiBB” or “the Company”), which develops EndoDrill® – the world’s first market-cleared powered biopsy...

Read more

  • Press Releases

March 18, 2025

Successful Live Broadcasted Patient Case with EndoDrill® GI in Porto, Portugal

The cancer diagnostics company BiBBInstruments AB (“BiBB” or “the Company”), which develops EndoDrill® – the world’s first CE-marked electric-driven biopsy instrument...

Read more

  • Press Releases

February 21, 2025

First liver cases with EndoDrill GI performed in the USA

The cancer diagnostics company BiBBInstruments AB (“BiBB” or the “Company”), the developer of EndoDrill® – the world’s first market-cleared powered biopsy...

Read more

No matches found.

Show all news

News & media / Media coverage

Various articles about BiBB

2025

BioStock March 26, 2025, BiBBs’ founder on clinical evaluations of EndoDrill GI
Link to the article

BioStock January 28, 2025, BiBBInstruments CEO: “First order sends positive signals”
Link to the article

2024

BioStock November 19, 2024, “BiBBInstrument’ founder on the Sahlgrenska evaluation”.
Link to the article

BioStock November 12, 2024, “BiBBInstrument’s CEO: “Distributors are contacting us”
Link to the article

BioStock September 27, 2024, “BiBB comments on the growing interest in EndoDrill GI”.
Link to the article

BioStock September 6, 2024, BiBB’s CEO: “Zagreb confirms good samples and short learning curve”.
Link to the article

BioStock June 12, 2024, “BiBBInstruments’ technology gets nod in medical journal”.
Link to the article

BioStock May 22, 2024, “Interest in BiBBInstruments’ EndoDrill GI continues to increase”.
Link to the article

BioStock May 6, 2024, “EndoDrill seen as promising new EUS technology”.
Link to the article

BioStock April 11, 2024, BiBB’s CEO: “Patient cases fortify our confidence in EndoDrill”.
Link to the article

Dr. Antonio Mendoza-Ladd, Medical Director of Endoscopy at UC Davis Health, is interviewed in the US media after the first patient cases with EndoDrill GI on February 26, 2024.
Link to article and video

UC Davis Health Hospital in Sacramento, USA, reports on the first successful patient cases with EndoDrill GI on February 13, 2024, “UC Davis Health performs world’s first endoscopic, ultrasound-guided biopsy with new needle“.
Link to the article 

BioStock February 26, 2024, BiBBInstruments expands patent protection to Japan.
Link to the article

BioStock February 12, 2024, BiBB’s founder on the first US clinical cases with EndoDrill.
Link to the article

BioStock February 7, 2024, BiBB’s CEO: “European CE approval is a significant milestone”.
Link to the article

2023

BioStock December 20, 2023, BiBBInstruments’ EndoDrill premier received with enthusiasm.
Link to the article

BioStock November 14, 2023, BiBBInstruments’ CEO: “Exciting times ahead”.
Link to the article

BioStock October 11, 2023, BiBB Founder’s Quest to Transform Cancer Diagnostics.
Link to the article

BioStock, August 30, 2023, BiBB coming off strong first half of 2023.
Link to the article

BioStock, June 12, 2023, CMO comments on promising results in bladder cancer.
Link to the article

BioStock, May 23, 2023, Full speed ahead for BiBBInstruments after FDA clearance.
Link to the article

BioStock, April 20, 2023, FDA clearance opens US market for BiBBInstruments.
Link to the article

BioStock, Mar 27, 2023, BiBBInstruments aims to revolutionise pancreatic cancer diagnostics
Link to the article

BioStock, Feb 13, 2023, BiBBInstruments eyes an eventful 2023
Link to the article

BioStock, Jan 10, 2023, BiBBInstruments comments on upcoming patent approval
Link to the article

2022

BioStock, Nov 15, 2022, BiBBInstruments comments on its Q3 report
Link to the article

BioStock, Aug 31, 2022, BiBBInstruments ready for active near-term future
Link to the article

BioStock, Aug 3, 2022, BiBBInstruments completes bladder cancer study
Link to the article

BioStock, June 23, 2022, BiBBInstruments aims for US market entry in 2023
Link to the article

BioStock, June 10, 2022, BiBBInstruments successfully participated in DDW conference
Link to the article

BioStock, May 13, 2022, Strengthened financial muscle for BiBBInstruments
Link to the article

BioStock, Apr 20, 2022, BiBBInstruments at forefront of cancer diagnostics revolution
Link to the article

BioStock, Feb 15, 2022, BiBBInstruments kicks off 2022 with capital raise
Link to the article

BioStock, Jan 13, 2022, Key steps taken by BiBBInstruments in 2021
Link to the article

2021

BioStock, Nov 25, 2021, BiBBInstruments’ cancer study comes to early end after convincing data
Link to the article

BioStock, Oct 26, 2021, BiBBInstruments aims high in cancer diagnostics industry
Link to the article

BioStock, Aug 27, 2021, Show of resilience from BiBBInstruments during Q2 trials
Link to the article

BioStock, May 25, 2021, BiBBInstruments resumes key clinical trials
Link to the article

BioStock, May 17, 2021, BiBBInstruments remains optimistic despite temporary pause in studies
Link to the article

BioStock, April 9, 2021, BiBBinstruments submits third international patent application
Link to the article

BioStock, March 16, 2021, BiBBInstruments initiates clinical trial in bladder cancer
Link to the article

BioStock, March 10, 2021, BiBBInstruments brings new vision to cancer diagnostics
Link to the article

Link to the Swedish section for News & Media

News & media / Congresses

BiBB’s team will attend the following meetings and congresses in 2025.

ESGE Days in Barcelona, 3–4 April, 2025

Link to the congress

DDW in San Diego, 3–6 May, 2025

Link to the congress

News & media / Image gallery

In the image library you’ll find photos, portraits and logos.

Logotype BiBBInstruments.

Download zip file

Logotype EndoDrill®.

Download zip file

Logotype EndoDrill® GI.

Download zip file

Logotype EndoDrill® URO.

Download zip file

Logotype EndoDrill® EBUS.

Download zip file

EndoDrill® GI.

Download zip file

EndoDrill® GI.

Download zip file

Ultra-flexible needle.

Download zip file

High-speed Rotating Core Needle.

Download zip file

EndoDrill® GI.

Download zip file

Complete EndoDrill® System.

Download zip file

Tissue acquisition using EndoDrill® GI.

Download zip file

Setup of EndoDrill® GI System.

Download zip file

Tissue acquisition using EndoDrill® EBUS.

Download zip file

Fredrik Lindblad, CEO.

Download zip file

Erik von Schenck, Chairman of the Board.

Download zip file

News & media / Video library

Presentation av BiBB på Aktiedagen i Göteborg den 16 maj 2022

Presentation av EndoDrill Model X 2021 (kort version 1:56 min)

Presentation av EndoDrill Model X 2021 (lång version 4:24 min)

BiBBInstruments strävar efter tillväxt hos både nya och befintliga kunder (hösten 2018)

BiBBInstruments på Sedermeradagen den 7 november 2018

BioStock Börsrapport – BiBBInstruments den 29 maj 2018

BiBBInstruments på Sedermeradagen den 15 maj 2018

BiBBInstruments Live på AktieTorget den 4 oktober 2017

BiBBInstrument går in i kommersialiseringsfas den 13 september 2017

New invention for better cancer diagnostic developed by MD Charles Walther, Lund University den 5 september 2013

BiBBInstruments AB

Medicon Village, SE-223 81 Lund, Sweden
Visiting address: Scheeletorget 1, Lund
Telephone: +46 708 99 94 86
E-mail: info@bibbinstruments.com

Follow the journey
towards better cancer
diagnostics on social media:

  • LinkedIn
  • X
  • YouTube

All content published on this site is protected by international copyright laws. We care about your integrity. Read our integrity policy.